Evidence map›Paper›PMID 34494844›Full record

ArticleMolecular pharmaceutics2021

On-Demand Drug Release from Click-Refillable Drug Depots.

Sandeep Palvai, Christopher T Moody, Sharda Pandit, Yevgeny Brudno

Open access · greenAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sandeep PalvaiJoint Department of Biomedical Engineering, University of North Carolina and North Carolina State University, Raleigh, North Carolina 27607, United States.
Christopher T MoodyJoint Department of Biomedical Engineering, University of North Carolina and North Carolina State University, Raleigh, North Carolina 27607, United States.
Sharda PanditJoint Department of Biomedical Engineering, University of North Carolina and North Carolina State University, Raleigh, North Carolina 27607, United States.
Yevgeny BrudnoJoint Department of Biomedical Engineering, University of North Carolina and North Carolina State University, Raleigh, North Carolina 27607, United States.ORCID 0000-0003-2963-3293
North Carolina State University · USUniversity of North Carolina at Chapel Hill · US

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
Epidemiologic Case-control Study of Barrett's EsophagusK23DK059311 · NIDDK · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SHAHEEN, NICHOLAS J · 2001 to 2005
$626k
Image-guided, ultrasound-enhanced long-term intracranial drug deliveryR21CA246414 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI BRUDNO, YEVGENY, DAYTON, PAUL A · 2020 to 2021
$369k
NCATS NIH HHS UL1 TR002489NCI NIH HHS R21 CA246414NIDDK NIH HHS K23 DK059311
6 · The paper itself

Abstract

Stimuli-responsive, on-demand release of drugs from drug-eluting depots could transform the treatment of many local diseases, providing intricate control over local dosing. However, conventional on-demand drug release approaches rely on locally implanted drug depots, which become spent over time and cannot be refilled or reused without invasive procedures. New strategies to noninvasively refill drug-eluting depots followed by on-demand release could transform clinical therapy. Here we report an on-demand drug delivery paradigm that combines bioorthogonal click chemistry to locally enrich protodrugs at a prelabeled site and light-triggered drug release at the target tissue. This approach begins with introduction of the targetable depot through local injection of chemically reactive azide groups that anchor to the extracellular matrix. The anchored azide groups then capture blood-circulating protodrugs through bioorthogonal click chemistry. After local capture and retention, active drugs can be released through external light irradiation. In this report, a photoresponsive protodrug was constructed consisting of the chemotherapeutic doxorubicin (Dox), conjugated to dibenzocyclooctyne (DBCO) through a photocleavable ortho-nitrobenzyl linker. The protodrug exhibited excellent on-demand light-triggered Dox release properties and light-mediated

Indexed as

Delayed-Action PreparationsDrug LiberationAnimalsAntineoplastic AgentsCell Line, TumorClick ChemistryDoxorubicinDrug Delivery SystemsFluorescent DyesHumansMiceAntineoplastic AgentsDelayed-Action PreparationsDoxorubicinFluorescent Dyesbioorthogonalclick chemistrydrug deliveryphotocleavagestimuli-responsive

Identifiers

PMID34494844
PMCPMC8560212
OpenAlexW3198387483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.